Work

Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative breast cancer (TNBC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.560

Authors: Kate Ida Lathrop, Virginia G. Kaklamani, Andrew Jacob Brenner, Rong Li, Alia Nazarullah, Sarah Hackman, Courtney Thomas, Jonathan Gelfond, Marisa Rodriguez, Richard Elledge

Institutions: Mays Cancer Center at UT Health San Antonio, USC Norris Comprehensive Cancer Center, The University of Texas at San Antonio Health Science Center, George Washington University, The University of Texas at San Antonio

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030998444

Cites:

Cited by: 12

Related to: 10